{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:03Z","timestamp":1792782963203,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430116"],"award-info":[{"award-number":["82430116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Medical Health Collaborative High-Quality Traditional Chinese Medicine Research and Development Project","award":["zyygzl-2025-022"],"award-info":[{"award-number":["zyygzl-2025-022"]}]},{"name":"the \"Jie Bang Gua Shuai\" Open Bidding Project of Beijing University of Chinese Medicine","award":["2023-JYB-JBZD-048"],"award-info":[{"award-number":["2023-JYB-JBZD-048"]}],"id":[{"id":"https:\/\/ror.org\/05damtm70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07972-6","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:41:08Z","timestamp":1791520868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut Microbiota and Its Metabolites in the Prognosis of Coronary Heart Disease: A Systematic Review and Mechanistic Insights"],"prefix":"10.1007","author":[{"given":"Weiting","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"7972_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.08.015","author":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators","year":"2025","unstructured":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990\u20132023. J Am Coll Cardiol. 2025. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.015.","journal-title":"J Am Coll Cardiol"},{"key":"7972_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425.","journal-title":"Eur Heart J"},{"key":"7972_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.3926","author":"PH Stone","year":"2023","unstructured":"Stone PH, Libby P, Boden WE. Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management-The Plaque Hypothesis: A Narrative Review. JAMA Cardiol. 2023. https:\/\/doi.org\/10.1001\/jamacardio.2022.3926.","journal-title":"JAMA Cardiol"},{"key":"7972_CR4","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16113","author":"JB Larsen","year":"2021","unstructured":"Larsen JB, Hvas AM. Fibrin clot properties in coronary artery disease: new determinants and prognostic markers. Pol Arch Intern Med. 2021. https:\/\/doi.org\/10.20452\/pamw.16113.","journal-title":"Pol Arch Intern Med"},{"key":"7972_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"key":"7972_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00091","author":"P Leon-Mimila","year":"2019","unstructured":"Leon-Mimila P, Wang J, Huertas-Vazquez A. Relevance of Multi-Omics Studies in Cardiovascular Diseases. Front Cardiovasc Med. 2019. https:\/\/doi.org\/10.3389\/fcvm.2019.00091.","journal-title":"Front Cardiovasc Med"},{"key":"7972_CR7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-060513-093205","author":"JM Brown","year":"2015","unstructured":"Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015. https:\/\/doi.org\/10.1146\/annurev-med-060513-093205.","journal-title":"Annu Rev Med"},{"key":"7972_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-026-07875-6","author":"C Vrints","year":"2026","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al. The gut microbiota-metabolite-host axis in cardiometabolic diseases: bridging bench to bedside. Cardiovasc Drugs Ther. 2026. https:\/\/doi.org\/10.1007\/s10557-026-07875-6.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7972_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316242","author":"M Witkowski","year":"2020","unstructured":"Witkowski M, Weeks TL, Hazen SL. Gut Microbiota and Cardiovascular Disease. Circ Res. 2020. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316242.","journal-title":"Circ Res"},{"key":"7972_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.309715","author":"WH Tang","year":"2017","unstructured":"Tang WH, Kitai T, Hazen SL. Gut Microbiota in Cardiovascular Health and Disease. Circ Res. 2017. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309715.","journal-title":"Circ Res"},{"key":"7972_CR11","unstructured":"Wells G, Shea B, O\u2019Connell D et al. Ottawa Hospital Research Institute. https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale (accessed 20 February 2026)."},{"key":"7972_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038175","author":"P Zhao","year":"2025","unstructured":"Zhao P, Dong N, Wang Y, et al. Association of Circulating Phenylacetylglutamine With Multi-Vessel Coronary Disease Severity and Outcomes in ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc. 2025. https:\/\/doi.org\/10.1161\/JAHA.124.038175.","journal-title":"J Am Heart Assoc"},{"key":"7972_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf181","author":"J Arenas-Montes","year":"2025","unstructured":"Arenas-Montes J, Alcala-Diaz JF, Garcia-Fernandez H, et al. A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf181.","journal-title":"Eur Heart J"},{"key":"7972_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073400","author":"TY Tsai","year":"2025","unstructured":"Tsai TY, Aldujeli A, Haq A, et al. Trimethylamine N-Oxide as a Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling After STEMI. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26073400.","journal-title":"Int J Mol Sci"},{"key":"7972_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf661","author":"FA Wenzl","year":"2025","unstructured":"Wenzl FA, Wang P, Kahles F, et al. Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf661.","journal-title":"Eur Heart J"},{"key":"7972_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2024.05.007","author":"A Aleksova","year":"2025","unstructured":"Aleksova A, Fluca AL, Stornaiuolo M, et al. Intra-hospital variation of gut microbiota product, trimethylamine N-oxide (TMAO), predicts future major adverse cardiovascular events after myocardial infarction. Hellenic J Cardiol. 2025. https:\/\/doi.org\/10.1016\/j.hjc.2024.05.007.","journal-title":"Hellenic J Cardiol"},{"key":"7972_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1360861","author":"X Yu","year":"2024","unstructured":"Yu X, Wang Y, Yang R, et al. Trimethylamine N-oxide predicts cardiovascular events in coronary artery disease patients with diabetes mellitus: a prospective cohort study. Front Endocrinol (Lausanne). 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1360861.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7972_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2022.12.013","author":"S Zhao","year":"2023","unstructured":"Zhao S, Tian Y, Wang S, et al. Prognostic value of gut microbiota-derived metabolites in patients with ST-segment elevation myocardial infarction. Am J Clin Nutr. 2023. https:\/\/doi.org\/10.1016\/j.ajcnut.2022.12.013.","journal-title":"Am J Clin Nutr"},{"key":"7972_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2232369","author":"TT Liu","year":"2023","unstructured":"Liu TT, Wang J, Liang Y, et al. The level of serum total bile acid is related to atherosclerotic lesions, prognosis and gut Lactobacillus in acute coronary syndrome patients. Ann Med. 2023. https:\/\/doi.org\/10.1080\/07853890.2023.2232369.","journal-title":"Ann Med"},{"key":"7972_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9110380","author":"N Li","year":"2022","unstructured":"Li N, Wang Y, Zhou J, et al. Association between the Changes in Trimethylamine N-Oxide-Related Metabolites and Prognosis of Patients with Acute Myocardial Infarction: A Prospective Study. J Cardiovasc Dev Dis. 2022. https:\/\/doi.org\/10.3390\/jcdd9110380.","journal-title":"J Cardiovasc Dev Dis"},{"key":"7972_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqac170","author":"Q Li","year":"2022","unstructured":"Li Q, You Y, Zeng Y, et al. Associations between plasma tryptophan and indole-3-propionic acid levels and mortality in patients with coronary artery disease. Am J Clin Nutr. 2022. https:\/\/doi.org\/10.1093\/ajcn\/nqac170.","journal-title":"Am J Clin Nutr"},{"key":"7972_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.09.026","author":"C Ringel","year":"2021","unstructured":"Ringel C, Dittrich J, Gaudl A, et al. Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome. Atherosclerosis. 2021. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.026.","journal-title":"Atherosclerosis"},{"key":"7972_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.016","author":"I Nemet","year":"2020","unstructured":"Nemet I, Saha PP, Gupta N, et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.02.016.","journal-title":"Cell"},{"key":"7972_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131261","author":"A Davies","year":"2023","unstructured":"Davies A, Wenzl FA, Li XS, et al. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes. Int J Cardiol. 2023. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131261.","journal-title":"Int J Cardiol"},{"key":"7972_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw582","author":"XS Li","year":"2017","unstructured":"Li XS, Obeid S, Klingenberg R, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017. https:\/\/doi.org\/10.1093\/eurheartj\/ehw582.","journal-title":"Eur Heart J"},{"key":"7972_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002816","author":"V Senthong","year":"2016","unstructured":"Senthong V, Wang Z, Li XS, et al. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. J Am Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.115.002816.","journal-title":"J Am Heart Assoc"},{"key":"7972_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015331","author":"B Gencer","year":"2020","unstructured":"Gencer B, Li XS, Gurmu Y, et al. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial. J Am Heart Assoc. 2020. https:\/\/doi.org\/10.1161\/JAHA.119.015331.","journal-title":"J Am Heart Assoc"},{"key":"7972_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2021.12.007","author":"C Liu","year":"2022","unstructured":"Liu C, Sun Z, Shali S, et al. The gut microbiome and microbial metabolites in acute myocardial infarction. J Genet Genomics. 2022. https:\/\/doi.org\/10.1016\/j.jgg.2021.12.007.","journal-title":"J Genet Genomics"},{"key":"7972_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.687827","author":"J Gao","year":"2021","unstructured":"Gao J, Wang J, Zhao LL, et al. Gut Lactobacillus Level Is a Predictive Marker for Coronary Atherosclerotic Lesions Progress and Prognosis in Patients With Acute Coronary Syndrome. Front Cell Infect Microbiol. 2021. https:\/\/doi.org\/10.3389\/fcimb.2021.687827.","journal-title":"Front Cell Infect Microbiol"},{"key":"7972_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00895-8","author":"JW Jang","year":"2024","unstructured":"Jang JW, Capaldi E, Smith T, et al. Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis. Mol Med. 2024. https:\/\/doi.org\/10.1186\/s10020-024-00895-8.","journal-title":"Mol Med"},{"key":"7972_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/nature09922","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011. https:\/\/doi.org\/10.1038\/nature09922.","journal-title":"Nature"},{"key":"7972_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.11.016","author":"J Geng","year":"2018","unstructured":"Geng J, Yang C, Wang B, et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomed Pharmacother. 2018. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.016.","journal-title":"Biomed Pharmacother"},{"key":"7972_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.125.323047","author":"J Cheng","year":"2025","unstructured":"Cheng J, Cheng M, Sinha S, et al. Trimethylamine-N-Oxide Affects Cell Type-Specific Pathways and Networks in Mouse Aorta to Promote Atherosclerotic Plaque Vulnerability. Arterioscler Thromb Vasc Biol. 2025. https:\/\/doi.org\/10.1161\/ATVBAHA.125.323047.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7972_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113209","author":"W Bingyu","year":"2024","unstructured":"Bingyu W, Jun Q, Bingyang L, et al. Trimethylamine N-oxide promotes PERK-mediated endothelial-mesenchymal transition and apoptosis thereby aggravates atherosclerosis. Int Immunopharmacol. 2024. https:\/\/doi.org\/10.1016\/j.intimp.2024.113209.","journal-title":"Int Immunopharmacol"},{"key":"7972_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.11.055","author":"Z Wang","year":"2015","unstructured":"Wang Z, Roberts AB, Buffa JA, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 2015. https:\/\/doi.org\/10.1016\/j.cell.2015.11.055.","journal-title":"Cell"},{"key":"7972_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09263-w","author":"A Mastrangelo","year":"2025","unstructured":"Mastrangelo A, Robles-Vera I, Ma\u00f1anes D, et al. Imidazole propionate is a driver and therapeutic target in atherosclerosis. Nature. 2025. https:\/\/doi.org\/10.1038\/s41586-025-09263-w.","journal-title":"Nature"},{"key":"7972_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.124.322346","author":"V Nageswaran","year":"2025","unstructured":"Nageswaran V, Carreras A, Reinshagen L, et al. Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2025. https:\/\/doi.org\/10.1161\/ATVBAHA.124.322346.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7972_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55084-2","author":"Z Li","year":"2024","unstructured":"Li Z, Gu M, Zaparte A, et al. Alcohol-induced gut microbial reorganization and associated overproduction of phenylacetylglutamine promotes cardiovascular disease. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-55084-2.","journal-title":"Nat Commun"},{"key":"7972_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034588","author":"T Nakano","year":"2019","unstructured":"Nakano T, Katsuki S, Chen M, et al. Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling. Circulation. 2019. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034588.","journal-title":"Circulation"},{"key":"7972_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106763","author":"X Li","year":"2020","unstructured":"Li X, Lu Z, Zhou F, et al. Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro. Vascul Pharmacol. 2020. https:\/\/doi.org\/10.1016\/j.vph.2020.106763.","journal-title":"Vascul Pharmacol"},{"key":"7972_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2020.11.009","author":"WJ Chen","year":"2020","unstructured":"Chen WJ, Lai YJ, Lee JL, et al. CREB\/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia. Atherosclerosis. 2020. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.11.009.","journal-title":"Atherosclerosis"},{"key":"7972_CR42","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.60.450","author":"H Shimizu","year":"2014","unstructured":"Shimizu H, Hagio M, Iwaya H, et al. Deoxycholic acid is involved in the proliferation and migration of vascular smooth muscle cells. J Nutr Sci Vitaminol (Tokyo). 2014. https:\/\/doi.org\/10.3177\/jnsv.60.450.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"7972_CR43","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0007502020","author":"S Miyazaki-Anzai","year":"2021","unstructured":"Miyazaki-Anzai S, Masuda M, Shiozaki Y, et al. Free Deoxycholic Acid Exacerbates Vascular Calcification in CKD through ER Stress-Mediated ATF4 Activation. Kidney360. 2021. https:\/\/doi.org\/10.34067\/KID.0007502020.","journal-title":"Kidney360"},{"key":"7972_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01219-9","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian YP, Zhang YN, et al. Short-chain fatty acids in diseases. Cell Commun Signal. 2023. https:\/\/doi.org\/10.1186\/s12964-023-01219-9.","journal-title":"Cell Commun Signal"},{"key":"7972_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2025.100496","author":"Y Nami","year":"2025","unstructured":"Nami Y, Shaghaghi Ranjbar M, Modarres Aval M, et al. Harnessing Lactobacillus-derived SCFAs for food and health: Pathways, genes, and functional implications. Curr Res Microb Sci. 2025. https:\/\/doi.org\/10.1016\/j.crmicr.2025.100496.","journal-title":"Curr Res Microb Sci"},{"key":"7972_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501707","author":"R Hua","year":"2025","unstructured":"Hua R, Ding N, Hua Y, et al. Ligilactobacillus Murinus and Lactobacillus Johnsonii Suppress Macrophage Pyroptosis in Atherosclerosis through Butyrate-GPR109A-GSDMD Axis. Adv Sci (Weinh). 2025. https:\/\/doi.org\/10.1002\/advs.202501707.","journal-title":"Adv Sci (Weinh)"},{"key":"7972_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14933","author":"Y Du","year":"2020","unstructured":"Du Y, Li X, Su C, et al. Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice. Br J Pharmacol. 2020. https:\/\/doi.org\/10.1111\/bph.14933.","journal-title":"Br J Pharmacol"},{"key":"7972_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105681","author":"Q Tian","year":"2021","unstructured":"Tian Q, Leung FP, Chen FM, et al. Butyrate protects endothelial function through PPAR\u03b4\/miR-181b signaling. Pharmacol Res. 2021. https:\/\/doi.org\/10.1016\/j.phrs.2021.105681.","journal-title":"Pharmacol Res"},{"key":"7972_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033714","author":"N Yoshida","year":"2018","unstructured":"Yoshida N, Emoto T, Yamashita T, et al. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Circulation. 2018. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033714.","journal-title":"Circulation"},{"key":"7972_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03360-8","author":"B Jing","year":"2025","unstructured":"Jing B, Gao Y, Wang L, et al. Probiotic membrane vesicles ameliorate atherosclerotic plaques by promoting lipid efflux and polarization of foamy macrophages. J Nanobiotechnol. 2025. https:\/\/doi.org\/10.1186\/s12951-025-03360-8.","journal-title":"J Nanobiotechnol"},{"key":"7972_CR51","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00595-24","author":"Z Wang","year":"2024","unstructured":"Wang Z, Yang S, Tong L, et al. eIF6 deficiency regulates gut microbiota, decreases systemic inflammation, and alleviates atherosclerosis. mSystems. 2024. https:\/\/doi.org\/10.1128\/msystems.00595-24.","journal-title":"mSystems"},{"key":"7972_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07788-w","author":"Z Chen","year":"2026","unstructured":"Chen Z, Zhang Y, Qian C, et al. The Role of the Pentose Phosphate Pathway in Cardiovascular Diseases. Cardiovasc Drugs Ther. 2026. https:\/\/doi.org\/10.1007\/s10557-025-07788-w.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7972_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152934","author":"O Ozgun Acar","year":"2025","unstructured":"Ozgun Acar O. Probiotic modulation of energy metabolism ameliorates experimental autoimmune encephalomyelitis via Nrf2-associated pentose phosphate pathway activation. Biochem Biophys Res Commun. 2025. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152934.","journal-title":"Biochem Biophys Res Commun"},{"key":"7972_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/09637486.2017.1305353","author":"A Tahara","year":"2017","unstructured":"Tahara A, Tahara N, Yamagishi SI, et al. Ratio of serum levels of AGEs to soluble RAGE is correlated with trimethylamine-N-oxide in non-diabetic subjects. Int J Food Sci Nutr. 2017. https:\/\/doi.org\/10.1080\/09637486.2017.1305353.","journal-title":"Int J Food Sci Nutr"},{"key":"7972_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07639-0","author":"B Wang","year":"2025","unstructured":"Wang B, Jiang T, Qi Y, et al. AGE-RAGE Axis and Cardiovascular Diseases: Pathophysiologic Mechanisms and Prospects for Clinical Applications. Cardiovasc Drugs Ther. 2025. https:\/\/doi.org\/10.1007\/s10557-024-07639-0.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7972_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07732-y","author":"X Lu","year":"2026","unstructured":"Lu X, Luo Q, Yu D, et al. The Emerging Role of Lactate and Lactylation Modifications in the Pathophysiology of Atherosclerotic Cardiovascular Diseases. Cardiovasc Drugs Ther. 2026. https:\/\/doi.org\/10.1007\/s10557-025-07732-y.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7972_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70048","author":"C Wang","year":"2025","unstructured":"Wang C, Liu Z, Zhou T, et al. Gut microbiota-derived butyric acid regulates calcific aortic valve disease pathogenesis by modulating GAPDH lactylation and butyrylation. Imeta. 2025. https:\/\/doi.org\/10.1002\/imt2.70048.","journal-title":"Imeta"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07972-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:41:20Z","timestamp":1791520880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07972-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":57,"alternative-id":["7972"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07972-6","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}